Announcement on the Resumption of Conversion for Xianle Convertible Bonds

Sirio Pharma Co., Ltd.·July 30, 2026·2 pages

✨ AI Summary

Xianle Convertible Bonds will resume conversion on July 31, 2026, after a temporary suspension for a put option exercise period. The suspension, from July 24 to July 30, 2026, was due to the stock price falling below 70% of the conversion price in the final two years of the bond's term. Bondholders are advised to pay attention.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Bond Code: 123113; Bond Name: Xianle Convertible Bonds; Announcement Code: 2026-106

Xianle Health Technology Co., Ltd.

Announcement on the Resumption of Conversion for "Xianle Convertible Bonds"

The information disclosed by this company and its board of directors is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.

Special Notice:

Bond Code: 123113; Bond Name: Xianle Convertible Bonds
Conversion Period Start and End Dates: October 25, 2021, to April 18, 2027
Suspension of Conversion Period: July 24, 2026, to July 30, 2026
Resumption of Conversion Date: July 31, 2026

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.